GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Blackrock Health Sciences Trust (NYSE:BME) » Definitions » Cash Flow from Operations

Blackrock Health Sciences Trust (Blackrock Health Sciences Trust) Cash Flow from Operations : $32.02 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Blackrock Health Sciences Trust Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Dec. 2023, Blackrock Health Sciences Trust's Net Income From Continuing Operations was $8.71 Mil. Its Depreciation, Depletion and Amortization was $0.00 Mil. Its Change In Working Capital was $-2.97 Mil. Its cash flow from deferred tax was $0.00 Mil. Its Cash from Discontinued Operating Activities was $0.00 Mil. Its Asset Impairment Charge was $0.00 Mil. Its Stock Based Compensation was $0.00 Mil. And its Cash Flow from Others was $12.29 Mil. In all, Blackrock Health Sciences Trust's Cash Flow from Operations for the six months ended in Dec. 2023 was $18.03 Mil.


Blackrock Health Sciences Trust Cash Flow from Operations Historical Data

The historical data trend for Blackrock Health Sciences Trust's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blackrock Health Sciences Trust Cash Flow from Operations Chart

Blackrock Health Sciences Trust Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Operations
Get a 7-Day Free Trial -14.10 -19.35 -21.56 -0.87 32.02

Blackrock Health Sciences Trust Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.53 -2.29 1.42 13.99 18.03

Blackrock Health Sciences Trust Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Blackrock Health Sciences Trust's Cash Flow from Operations for the fiscal year that ended in Dec. 2023 is calculated as:

Blackrock Health Sciences Trust's Cash Flow from Operations for the quarter that ended in Dec. 2023 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $32.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blackrock Health Sciences Trust  (NYSE:BME) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Blackrock Health Sciences Trust's net income from continuing operations for the six months ended in Dec. 2023 was $8.71 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Blackrock Health Sciences Trust's depreciation, depletion and amortization for the six months ended in Dec. 2023 was $0.00 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Blackrock Health Sciences Trust's change in working capital for the six months ended in Dec. 2023 was $-2.97 Mil. It means Blackrock Health Sciences Trust's working capital declined by $2.97 Mil from Jun. 2023 to Dec. 2023 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Blackrock Health Sciences Trust's cash flow from deferred tax for the six months ended in Dec. 2023 was $0.00 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Blackrock Health Sciences Trust's cash from discontinued operating Activities for the six months ended in Dec. 2023 was $0.00 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Blackrock Health Sciences Trust's asset impairment charge for the six months ended in Dec. 2023 was $0.00 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Blackrock Health Sciences Trust's stock based compensation for the six months ended in Dec. 2023 was $0.00 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Blackrock Health Sciences Trust's cash flow from others for the six months ended in Dec. 2023 was $12.29 Mil.


Blackrock Health Sciences Trust Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Blackrock Health Sciences Trust's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Blackrock Health Sciences Trust (Blackrock Health Sciences Trust) Business Description

Traded in Other Exchanges
N/A
Address
100 Bellevue Parkway, Wilmington, DE, USA, 19809
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
Executives
Arthur Philip Steinmetz director 50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman officer: Chief Compliance Officer 50 HUDSON YARDS, NEW YORK NY 10001
Lorenzo Flores director 2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman director P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris director 1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker officer: Chief Financial Officer C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Kyle Mcclements other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Christopher Accettella other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
H Erin Xie other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Cynthia Egan director 7117 BELLONA AVENUE, BALTIMORE MD 21212
Robert W Fairbairn director 55 EAST 52ND STREET, NEW YORK NY 10055
Catherine A. Lynch director 55 EAST 52ND STREET, NEW YORK NY 10055
Jonathan Diorio officer: Vice President 55 EAST 52ND STREET, NEW YORK NY 10055